Integrative Medicine as a New Treatment Model and the Future of Health Care Systems in the World in the Context of Rare Diseases

Purpose: This article aims to present integrative medicine as a new treatment model representing the future of health systems globally, including rare diseases. Design/Methodology/Approach: The article consists of three parts. The first one covers the definitions of integrative medicine as well as other terms. The second part of the study deals with the model of patient treatment in integrative medicine. It draws attention to a multidisciplinary and holistic approach to the treatment process. The third part, showing the possibility of using an integrated model in the management of a rare disease, refers to the example of childhood CLN2 dementia. The fourth part of the article focuses on the main challenges facing health systems in the world. Findings: Integrative medicine, combining conventional medicine with alternative medicine, is an innovative approach to the treatment process. It results from the need for individualized, holistic treatment of the patient. Integrative medicine is a challenge and the future of health systems globally in establishing interdisciplinary cooperation and educating medical professionals at the primary healthcare level. The integrated model responds to the needs of people suffering from rare diseases and their families. Practical Implications: Modern medicine should focus on improving communication between all participants of the treatment process and shaping good doctor-patient relations. Planning and policy making should involve conventional and alternative medicine practitioners, as specialists in both medical disciplines would be crucial in integrating health services. These services should be adapted to the culture and requirements of a given community. The integrated model addresses the challenges of rare disease management in the context of the patient and his family. Originality/Value: The concept of integrative medicine shows that the approach is justified in managing rare diseases, treated both causally and symptomatically. Furthermore, it explains the need to consider the perspective of the patient and his family - caregivers and healthy siblings.